Molecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review (Q39427752)

11 September 2017

title

Molecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review (English)

1 reference

11 September 2017

Giselli Scaini

4

0 references

João Quevedo

5

object named as

João Quevedo

1 reference

11 September 2017

author name string

Marcos Roberto de Oliveira

1

1 reference

11 September 2017

Aline Lukasievicz Chenet

2

1 reference

11 September 2017

Adriane Ribeiro Duarte

3

1 reference

11 September 2017

language of work or name

1 reference

10 July 2017

1 reference

11 September 2017

published in

Molecular Neurobiology

1 reference

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Targeting an old mechanism in a new disease-protection of glutamatergic dysfunction in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

A meta-analysis of depression severity and cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Cognitive deficits in the remitted state of unipolar depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

New approaches to antidepressant drug discovery: beyond monoamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Triple uptake inhibitors: therapeutic potential in depression and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The role of noradrenaline and selective noradrenaline reuptake inhibition in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Basic concepts in the study of diseases with complex genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The cellular neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Neurobiological mechanisms in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Mitochondrial respiration in blood platelets of depressive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Depressive behaviour in children diagnosed with a mitochondrial disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Stress and the brain: from adaptation to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Depression and oxidative stress: results from a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Evaluation of malondialdehyde, superoxide dismutase and catalase activity and their diagnostic value in drug naïve, first episode, non-smoker major depression patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The relevance of oxidative stress status in first episode and recurrent depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Increased plasma levels of 8-iso-PGF2alpha and IL-6 in an elderly population with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Depression and oxidative damage to lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Increased oxidative stress in patients with depression and its relationship to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Depression and possible cancer risk due to oxidative DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Psychosocial factors as a potential trigger of oxidative DNA damage in human leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Relationships between perceived workload, stress and oxidative DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Lower serum vitamin E concentrations in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Chronic variable stress induces oxidative stress and decreases butyrylcholinesterase activity in blood of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Oxidative stress and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Role of antioxidants in generalised anxiety disorder and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Depressive state relates to female oxidative DNA damage via neutrophil activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases in patients with psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Depressive symptoms are independently correlated with lipid peroxidation in a female population: comparison with vitamins and carotenoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

A Meta-Analysis of Oxidative Stress Markers in Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Is depression associated with increased oxidative stress? A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Cytokines and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Cytokines sing the blues: inflammation and the pathogenesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Increased M1/decreased M2 signature and signs of Th1/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Enrichment pathway analysis. The inflammatory genetic background in Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Evidence for an immune response in major depression: a review and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Imipramine reverses alterations in cytokines and BDNF levels induced by maternal deprivation in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Astrocytic abnormalities and global DNA methylation patterns in depression and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [¹¹C]PBR28 PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

TNFα in synaptic function: switching gears.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

An open-label, flexible-dose study of memantine in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Oxidative stress markers, cognitive functions, and psychosocial functioning in bipolar disorder: an empirical cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Animal models of neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Gene-environment interactions in psychiatry: joining forces with neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Chronic stress, acute stress, and depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Behaviour in the elevated plus-maze predicts coping after subchronic mild stress in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Resveratrol reverses the effects of chronic unpredictable mild stress on behavior, serum corticosterone levels and BDNF expression in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Effects of chronic mild stress on the oxidative parameters in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Effects of beta-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Strain differences in the chronic mild stress animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Effects of lamotrigine on behavior, oxidative parameters and signaling cascades in rats exposed to the chronic mild stress model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Effect of chronic administration of ketamine on the mitochondrial respiratory chain activity caused by chronic mild stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Minocycline protects against oxidative damage and alters energy metabolism parameters in the brain of rats subjected to chronic mild stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The medial forebrain bundle as a deep brain stimulation target for treatment resistant depression: A review of published data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Maternal separation in rats leads to anxiety-like behavior and a blunted ACTH response and altered neurotransmitter levels in response to a subsequent stressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Depressive behaviors and decreased expression of serotonin reuptake transporter in rats that experienced neonatal maternal separation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Parental depression: animal models of an adverse life event

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Post-weaning isolation promotes food intake and body weight gain in rats that experienced neonatal maternal separation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Lamotrigine treatment reverses depressive-like behavior and alters BDNF levels in the brains of maternally deprived adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Maternal deprivation induces depressive-like behaviour and alters neurotrophin levels in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Effects of Early Life Stress on Synaptic Plasticity in the Developing Hippocampus of Male and Female Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Intranasal oxytocin administration improves depression-like behaviors in adult rats that experienced neonatal maternal deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Adolescence fluoxetine increases serotonergic activity in the raphe-hippocampus axis and improves depression-like behaviors in female rats that experienced neonatal maternal separation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Dopamine overflow is increased in olfactory bulbectomized rats: an in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Fluoxetine modulates hippocampal cell signaling pathways implicated in neuroplasticity in olfactory bulbectomized mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Fluoxetine reverses depressive-like behaviors and increases hippocampal acetylcholinesterase activity induced by olfactory bulbectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

How olfaction disorders can cause depression? The role of habenular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Retracted: Suppression of Neuroinflammatory and Apoptotic Signaling Cascade by Curcumin Alone and in Combination with Piperine in Rat Model of Olfactory Bulbectomy Induced Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The olfactory bulbectomised rat as a model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Decreased hippocampal neurogenesis following olfactory bulbectomy is reversed by repeated citalopram administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Repeated exposure to corticosterone increases depression-like behavior in two different versions of the forced swim test without altering nonspecific locomotor activity or muscle strength.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: relevance to depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Corticosterone increases depression-like behavior, with some effects on predator odor-induced defensive behavior, in male and female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Synthesis of serotonin by a second tryptophan hydroxylase isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Vmat2 heterozygous mutant mice display a depressive-like phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Genes differentially expressed in CB1 knockout mice: involvement in the depressive-like phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Lack of CB1 receptor activity impairs serotonergic negative feedback

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Physiological effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Resveratrol and the mitochondria: From triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a mechanistic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Resveratrol: Biological and pharmaceutical properties as anticancer molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Resveratrol reverses chronic restraint stress-induced depression-like behaviour: Involvement of BDNF level, ERK phosphorylation and expression of Bcl-2 and Bax in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Neuroprotective properties of resveratrol in different neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Neuroprotective effects of resveratrol on damages of mouse cortical neurons induced by β-amyloid through activation of SIRT1/Akt1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Protective effects of resveratrol on aging-induced cognitive impairment in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Protective Effect of Silibinin on Learning and Memory Impairment in LPS-Treated Rats via ROS-BDNF-TrkB Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Absorption of three wine-related polyphenols in three different matrices by healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Preparation and in vitro/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The molecular neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Peripheral and Central Mechanisms of Stress Resilience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Chronic resveratrol treatment exerts antihyperalgesic effect and corrects co-morbid depressive like behaviors in mice with mononeuropathy: involvement of serotonergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Antidepressant-like effect of trans-resveratrol in chronic stress model: behavioral and neurochemical evidences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Current advances and trends in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

21 January 2018

Glutathione synthesis

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Oxidative stress and brain morphology in individuals with depression, anxiety and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Resveratrol ameliorates depressive-like behavior in repeated corticosterone-induced depression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The stress system in the human brain in depression and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Hypothalamic-pituitary-adrenal axis function in patients with chronic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Cortisol circadian rhythm alterations in psychotic major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The effect of trans-resveratrol on post-stroke depression via regulation of hypothalamus-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Resveratrol prevents impaired cognition induced by chronic unpredictable mild stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Piperine potentiates the effects of trans-resveratrol on stress-induced depressive-like behavior: involvement of monoaminergic system and cAMP-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Antidepressant effects of resveratrol in an animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Resveratrol abrogates lipopolysaccharide-induced depressive-like behavior, neuroinflammatory response, and CREB/BDNF signaling in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

What is the biological significance of BDNF mRNA targeting in the dendrites? Clues from epilepsy and cortical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Molecular bases of caloric restriction regulation of neuronal synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The Role of Proteases in Hippocampal Synaptic Plasticity: Putting Together Small Pieces of a Complex Puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Cellular and molecular mechanisms of the brain-derived neurotrophic factor in physiological and pathological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Neurotrophins: roles in neuronal development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Resveratrol counteracts lipopolysaccharide-induced depressive-like behaviors via enhanced hippocampal neurogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Adult brain neurogenesis and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Increasing Adult Hippocampal Neurogenesis is Sufficient to Reduce Anxiety and Depression-Like Behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Resveratrol Ameliorates the Depressive-Like Behaviors and Metabolic Abnormalities Induced by Chronic Corticosterone Injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Resveratrol Ameliorates the Anxiety- and Depression-Like Behavior of Subclinical Hypothyroidism Rat: Possible Involvement of the HPT Axis, HPA Axis, and Wnt/β-Catenin Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: significance in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Subclinical hypothyroidism increases the risk for depression in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Protein levels of β-catenin and activation state of glycogen synthase kinase-3β in major depression. A study with postmortem prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Resveratrol exerts antidepressant properties in the chronic unpredictable mild stress model through the regulation of oxidative stress and mTOR pathway in the rat hippocampus and prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The effects of antidepressants on the hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Lack of JWA Enhances Neurogenesis and Long-Term Potentiation in Hippocampal Dentate Gyrus Leading to Spatial Cognitive Potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Neuroprotection Through Rapamycin-Induced Activation of Autophagy and PI3K/Akt1/mTOR/CREB Signaling Against Amyloid-β-Induced Oxidative Stress, Synaptic/Neurotransmission Dysfunction, and Neurodegeneration in Adult Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

The protective effects of resveratrol on social stress-induced cytokine release and depressive-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Activation of ATP-sensitive potassium channel by iptakalim normalizes stress-induced HPA axis disorder and depressive behaviour by alleviating inflammation and oxidative stress in mouse hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Inflammation and depression: a causal or coincidental link to the pathophysiology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Influence of equol and resveratrol supplementation on health-related quality of life in menopausal women: A randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-017-0680-6

Effects of exogenous glucocorticoid on combat-related PTSD symptoms

21 January 2018

1 reference

12 December 2020

Psychiatric symptoms in a patient with the clinical features of MELAS.

1 reference

12 December 2020

Adrenal hormones suppress cell division in the adult rat dentate gyrus

1 reference

12 December 2020

The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression

1 reference

12 December 2020

Psychiatric comorbidity in 36 adults with mitochondrial cytopathies.

1 reference

12 December 2020

The olfactory bulbectomized rat as a model of depression

1 reference

12 December 2020

The role of the extracellular signal-regulated kinase signaling pathway in mood modulation.

1 reference

12 December 2020

Acute and chronic stress effects on open field activity in the rat: implications for a model of depression

1 reference

12 December 2020

Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients

1 reference

12 December 2020

Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression.

1 reference

12 December 2020

Chronic mild stress paradigm reduces sweet food intake in rats without affecting brain derived neurotrophic factor protein levels

1 reference

12 December 2020

Correlation between plasma levels of glutamate, alanine and serine with severity of depression

1 reference

12 December 2020

Effect of fluoxetine and resveratrol on testicular functions and oxidative stress in a rat model of chronic mild stress-induced depression.

1 reference

12 December 2020

Effects of antidepressant drugs on the behavior of olfactory bulbectomized and sham-operated rats

1 reference

12 December 2020

Stabilization and encapsulation of photosensitive resveratrol within yeast cell

1 reference

12 December 2020

Differences in mechanism of action between current and future antidepressants

1 reference

12 December 2020

Increased serum glutamate in depressed patients

1 reference

12 December 2020

MELAS point mutation with unusual clinical presentation

1 reference

12 December 2020

10.1007/S12035-017-0680-6

Identifiers

DOI

1 reference

11 September 2017

1 reference